APA

Lai D., Lin K., Sheu W. H., Lee M., Chen C., Lee W., Hung Y., Shen C., Chung T., Liu S. & Sheu M. (20170906). TPL2 (Therapeutic Targeting Tumor Progression Locus-2)/ATF4 (Activating Transcription Factor-4)/SDF1α (Chemokine Stromal Cell-Derived Factor-α) Axis Suppresses Diabetic Retinopathy. : Circulation research.

Chicago

Lai De-Wei, Lin Keng-Hung, Sheu Wayne Huey-Herng, Lee Maw-Rong, Chen Chung-Yu, Lee Wen-Jane, Hung Yi-Wen, Shen Chin-Chang, Chung Tsung-Ju, Liu Shing-Hwa and Sheu Meei-Ling. 20170906. TPL2 (Therapeutic Targeting Tumor Progression Locus-2)/ATF4 (Activating Transcription Factor-4)/SDF1α (Chemokine Stromal Cell-Derived Factor-α) Axis Suppresses Diabetic Retinopathy. : Circulation research.

Harvard

Lai D., Lin K., Sheu W. H., Lee M., Chen C., Lee W., Hung Y., Shen C., Chung T., Liu S. and Sheu M. (20170906). TPL2 (Therapeutic Targeting Tumor Progression Locus-2)/ATF4 (Activating Transcription Factor-4)/SDF1α (Chemokine Stromal Cell-Derived Factor-α) Axis Suppresses Diabetic Retinopathy. : Circulation research.

MLA

Lai De-Wei, Lin Keng-Hung, Sheu Wayne Huey-Herng, Lee Maw-Rong, Chen Chung-Yu, Lee Wen-Jane, Hung Yi-Wen, Shen Chin-Chang, Chung Tsung-Ju, Liu Shing-Hwa and Sheu Meei-Ling. TPL2 (Therapeutic Targeting Tumor Progression Locus-2)/ATF4 (Activating Transcription Factor-4)/SDF1α (Chemokine Stromal Cell-Derived Factor-α) Axis Suppresses Diabetic Retinopathy. : Circulation research. 20170906.